STRATA Skin Sciences

86 articles about STRATA Skin Sciences

• STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan

  4/9/2024

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the renewal of two distinct distribution agreements in international territories – one with the current exclusive distributor in China and a second with the current exclusive distributor in Japan.

• STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings

  3/27/2024

  STRATA Skin Sciences, Inc. announced financial results for the fourth quarter and full-year ended December 31, 2023.

• STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

  3/13/2024

  STRATA Skin Sciences, Inc. announced it plans to release its fourth quarter and full-year 2023 financial results on Wednesday, March 27, 2024.

• STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage

  3/7/2024

  STRATA Skin Sciences, Inc. announced an initiative aimed at expanding insurance coverage for essential treatments for conditions such as mycosis fungoides, lichen planus, alopecia areata, and cutaneous T-Cell lymphoma, with an initial targeted focus on expanding coverage for vitiligo and atopic dermatitis, skin diseases effecting up to 3 and 16 million people in the United States respectively.

• STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial

  2/26/2024

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced the successful amendment of its credit and security agreement with MidCap Financial Trust effective February 20, 2024.

• STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference   

  1/8/2024

  STRATA Skin Sciences, Inc. announced that the Company will be presenting a poster titled “Pulsed Broadband Light with Vacuum Suction and Needle Insert to Treat Acne” at the Maui Derm 2024 Meeting to be held at the Grand Wailea in Maui, Hawaii from January 22-26, 2024.

• STRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

  1/3/2024

  STRATA Skin Sciences, Inc. announced that it has received a notification letter from Nasdaq Stock Market LLC that the Company has been granted a 180-day extension, or until June 24, 2024, to regain compliance with Nasdaq’s minimum bid price rule.

• STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech

  12/29/2023

  STRATA Skin Sciences, Inc. announced the expansion of a direct distribution agreement with Kosmo Meditech, which is now assigned to Kosmo's corporate parent, Cutech, Inc., effective as of January 1, 2024, for a combination of direct capital sales and direct recurring revenue sales in Korea.

• STRATA Skin Science Announces Strengthening of Leadership Team

  12/4/2023

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced the promotion of Shmuel Gov to Chief Operating Officer.

• STRATA Skin Sciences Reports Third Quarter 2023 RevenueCompany to Host Conference Call and Webcast Today, November 14, 2023, at 4:30 PM ET

  11/14/2023

  STRATA Skin Sciences, Inc. announced financial results for the third quarter ended September 30, 2023.

• STRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

  11/2/2023

  STRATA Skin Sciences, Inc. today announced it plans to release its third quarter 2023 financial results on Tuesday, November 14, 2023.

• STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 31, 2023

  10/31/2023

  STRATA Skin Sciences, Inc. announced that, as previously reported on its Form 8-K filed on October 30, 2023, effective as of the close of trading on October 31, 2023, the Company granted equity-based awards, in accordance with Nasdaq Listing Rule 5635, to Dr. Dolev Rafaeli as an inducement material to Dr. Rafaeli entering into an employment agreement with the Company and commencing employment as its Vice-Chairman, Chief Executive Officer and President.

• STRATA Skin Science Announces Leadership Change

  10/30/2023

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that the Board of Directors and Bob Moccia have mutually agreed that Mr. Moccia will step down as the Company’s Chief Executive Officer and member of the Board, as of October 30, 2023.

• STRATA Skin Sciences to Participate in Upcoming Medical Conferences

  10/3/2023

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that the company will be participating in two medical conferences during October.

• STRATA Skin Sciences to Present at Upcoming October Conferences

  9/27/2023

  STRATA Skin Sciences, Inc. today announced that the company will be presenting at several conferences during October.

• STRATA Skin Sciences to Host Virtual KOL Event on XTRAC® and TheraClear®X

  8/24/2023

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it will host a virtual key opinion leader (KOL) event on XTRAC® and TheraClear®X on Wednesday, September 20, 2023, at 10:00 AM – 12:00 PM ET.

• STRATA Skin Sciences Reports Second Quarter 2023 Revenue

  8/9/2023

  STRATA Skin Sciences, Inc. announced financial results for the second quarter ended June 30, 2023.

• STRATA Skin Sciences to Participate in Upcoming August 2023 Conferences

  8/1/2023

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that the company will be participating in several conferences during August.

• STRATA Skin Sciences to Report Second Quarter 2023 Financial Results on August 9, 2023

  7/28/2023

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it plans to release its second quarter 2023 financial results on Wednesday, August 9, 2023.

• STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris

  7/11/2023

  STRATA Skin Sciences, Inc. announced the Journal of Clinical and Aesthetic Dermatology published a review and an expert perspectives article in the June 2023 Supplemental edition titled, “Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris.”